SG/PUT/EDWARDS LIFESCIENCES/80/0.1/21.03.25 | Market Closed - Boerse Frankfurt Warrants 20:49:53 05/06/2024 BST | ||
| 0.77 EUR | 0.00% |
|
| Current month | -6.10% | ||
| 1 month | -19.79% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 05/06/24 | 0.77 | 0.00% |
| 04/06/24 | 0.77 | +1.32% |
| 03/06/24 | 0.76 | -7.32% |
| 31/05/24 | 0.82 | +7.89% |
| 30/05/24 | 0.76 | -5.00% |
Real-time Boerse Frankfurt Warrants
Last update June 05, 2024 at 08:49 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SU6Q18 |
| ISIN | DE000SU6Q180 |
| Date issued | 08/01/2024 |
| Strike | 80 $ |
| Maturity | 21/03/2025 (289 Days) |
| Parity | 10 : 1 |
| Emission price | 1.67 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.7 € |
|---|---|
| Lowest since issue | 0.69 € |
| Spread | 0.01 € |
| Spread % | 1.28% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
87.07
USD
Average target price
96.17
USD
Spread / Average Target
+10.45%
- Stock Market
- Warrants
- Warrant
